Late-life depression and mortality: influence of gender and antidepressant use

被引:77
|
作者
Ryan, Joanne [1 ]
Carriere, Isabelle [1 ]
Ritchie, Karen [1 ]
Stewart, Robert [1 ]
Toulemonde, Gwladys [1 ,2 ]
Dartigues, Jean-Francois [3 ]
Tzourio, Christophe [4 ]
Ancelin, Marie-Laure [1 ]
机构
[1] Univ Montpellier, Hop Colombiere, INSERM, U888, Montpellier 5, France
[2] Kings Coll London, Inst Psychiat, London WC2R 2LS, England
[3] Univ Bordeaux, INSERM, U593, Montpellier, France
[4] Univ Paris, INSERM, U708, Montpellier, France
关键词
D O I
10.1192/bjp.bp.107.039164
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Depression may increase the risk of mortality among certain subgroups of older people, but the part played by antidepressants in this association has not been thoroughly explored. Aims To identify the characteristics of older populations who are most at risk of dying, as a function of depressive symptoms, gender and antidepressant use. Method Adjusted Cox proportional hazards models were used to determine the association between depression and/or antidepressant use and 4-year survival of 7363 community-dwelling elderly people. Major depressive disorder was evaluated using a standardised psychiatric examination based on DSM-IV criteria and depressive symptoms were assessed using the Center for Epidemiological Studies-Depression scale. Results Depressed men using antidepressants had the greatest risk of dying, with increasing depression severity corresponding to a higher hazard risk. Among women, only severe depression in the absence of treatment was significantly associated with mortality. Conclusions The association between depression and mortality is gender-dependent and varies according to symptom load and antidepressant use. Declaration of interest None.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [1] Antidepressant response in late-life depression
    Roose, SP
    Suthers, KM
    JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 : 4 - 8
  • [2] Outcomes for antidepressant trials in late-life depression
    Meyers, BS
    Bruce, ML
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (04) : 701 - 705
  • [3] An update on antidepressant pharmacotherapy in late-life depression
    Brender, Ram
    Mulsant, Benoit H.
    Blumberger, Daniel M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (14) : 1909 - 1917
  • [4] Treatment Course With Antidepressant Therapy in Late-Life Depression
    Irion, Klaus L.
    Muly, Sudha
    Hochhegger, Bruno
    Marchiori, Edson
    AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (04): : 446 - 446
  • [5] Critical review of antidepressant trials in late-life depression
    Koppel, J
    Greenwald, B
    Kramer, E
    Kremen, N
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 231 - 232
  • [6] Treatment Course With Antidepressant Therapy in Late-Life Depression
    Sheline, Yvette I.
    Disabato, Brianne M.
    Hranilovich, Jennifer
    Morris, Carrie
    D'Angelo, Gina
    Pieper, Carl
    Toffanin, Tommaso
    Taylor, Warren D.
    MacFall, James R.
    Wilkins, Consuelo
    Barch, Deanna M.
    Welsh-Bohmer, Kathleen A.
    Steffens, David C.
    Krishnan, Ranga R.
    Doraiswamy, P. Murali
    AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (11): : 1185 - 1193
  • [7] Optimal length of antidepressant trials in late-life depression
    Sackeim, HA
    Roose, SP
    Burt, T
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (04) : S34 - S37
  • [8] EFFECTS OF ANTIDEPRESSANT MEDICATION ON RCBF IN LATE-LIFE DEPRESSION
    NOBLER, MS
    SACKEIM, HA
    PROHOVNIK, I
    MOELLER, JR
    KRUEGER, RB
    ROOSE, SP
    BIOLOGICAL PSYCHIATRY, 1994, 35 (09) : 712 - 712
  • [9] Use of Antidepressants in Late-Life Depression
    Tarek K. Rajji
    Benoit H. Mulsant
    Francis E. Lotrich
    Cynthia Lokker
    Charles F. Reynolds
    Drugs & Aging, 2008, 25 : 841 - 853
  • [10] Is frailty a predictor of mortality in late-life depression?
    Arts, M.
    EUROPEAN PSYCHIATRY, 2022, 65 : S171 - S172